Table 5 Affordability in terms of the HAI method using number of day’s wages of a government worker required to pay for treatment with cancer medicine(s) [18]
No. | Medicine Name | Medicine Strength | Dosage Form | Target Pack Size | Medicine Type | SEP Median Price (ZAR) | Treatment (Number of vials needed per month) | Treatment Cost per month (ZAR) | Daily Wage (ZAR) (18) | Affordability (14) |
|---|---|---|---|---|---|---|---|---|---|---|
1 | Paclitaxel (Taxol) | 300 mg | vial | 1 | OB | 35.4918 | 1 | 35.4918 | 166.0800 | 0.2 |
2 | Paclitaxel | 300 mg | vial | 1 | LPG | 27.5465 | 1 | 27.5465 | 166.0800 | 0.2 |
3 | Doxorubicin (Adriblastina RD) | 10 mg | vial | 1 | OB | 72.9250 | 8 | 583.3996 | 166.0800 | 3.5 |
4 | Doxorubicin | 10 mg | vial | 1 | LPG | 20.3500 | 8 | 162.8000 | 166.0800 | 1.0 |
5 | Doxorubicin (Adriblastina CSV) | 50 mg | vial | 1 | OB | 315.5469 | 2 | 631.0938 | 166.0800 | 3.8 |
6 | Doxorubicin | 50 mg | vial | 1 | LPG | 213.4550 | 2 | 426.9100 | 166.0800 | 2.6 |
7 | Docetaxel | 20 mg | vial | 1 | LPG | 564.2920 | 4 | 2257.1680 | 166.0800 | 13.6 |
8 | Docetaxel (Taxotere) | 80 mg | vial | 1 | OB | 1490.2191 | 1 | 1490.2191 | 166.0800 | 9.0 |
9 | Docetaxel | 80 mg | vial | 1 | LPG | 564.2920 | 1 | 564.2920 | 166.0800 | 3.4 |
10 | Fluorouracil (Fluroblastin) | 500 mg | vial | 1 | OB | 4.3900 | 10 | 43.9000 | 166.0800 | 0.3 |
11 | Fluorouracil | 500 mg | vial | 1 | LPG | 34.2300 | 10 | 342.3000 | 166.0800 | 2.1 |
12 | Oxaliplatin | 50 mg | vial | 1 | LPG | 89.0000 | 2 | 178.0000 | 166.0800 | 1.1 |
13 | Oxaliplatin | 100 mg | vial | 1 | LPG | 89.0000 | 1 | 89.0000 | 166.0800 | 0.5 |
14 | Irinotecan (Campto) | 40 mg | vial | 1 | OB | 599.5800 | 9 | 5396.2200 | 166.0800 | 32.5 |
15 | Irinotecan | 40 mg | vial | 1 | LPG | 211.9561 | 9 | 1907.6045 | 166.0800 | 11.5 |
16 | Irinotecan (Campto) | 100 mg | vial | 1 | OB | 708.0000 | 4 | 2832.0000 | 166.0800 | 17.1 |
17 | Irinotecan | 100 mg | vial | 1 | LPG | 211.9529 | 4 | 847.8115 | 166.0800 | 5.1 |